Abstract:Selectivity of natural agonists for their cognate receptors is one of the hallmarks of the members of GPCR family, and it is crucial for the specificity of downstream signal-transduction. However, this selectivity often breaks down in the chemokine receptor subfamily, wherein a high degree of promiscuity is observed with one receptor recognizing multiple chemokines and one chemokine binding to multiple receptors. The molecular determinants of such a striking promiscuity for natural ligands in the chemokine-chemokine receptor system remain mostly elusive and represent an important knowledge gap in our current understanding. Here, we carry out a comprehensive transducer-coupling analysis, testing all known C-X-C chemokines on every C-X-C type chemokine receptor, to generate a global fingerprint of the selectivity and promiscuity encoded within this system. Taking lead from our finding, we determined cryo-EM structures of the most promiscuous receptor, CXCR2, in complex with every interacting chemokine, and deciphered the conserved molecular signatures and distinct binding modalities. While most chemokines position themselves on the receptor as a dimer, CXCL6 exhibits a monomeric binding pose induced by a previously unanticipated reorientation of its carboxyl-terminal α-helix, leading to disruption of the dimer interface. Surprisingly, one of the chemokines, CXCL5, induces a ligand-swapped dimer of CXCR2, the first of its kind observed in class A GPCRs, wherein each protomer of the ligand engages its own receptor without any discernible receptor-receptor interface. These unique observations provide a possible structural mechanism for inherent functional specialization encoded in chemokines despite their convergence to a common receptor. Furthermore, we also determined cryo-EM structures of CXCR3 in complex with G-protein-biased and β-arrestin-biased small molecule agonists that elucidate distinct allosteric modulations in the receptor driving their divergent transducer-coupling bias. Guided by structural analysis and experimental validation, we discover that in contrast to previously held notion, small molecule agonists of CXCR3 display robust agonism at CXCR7, an intrinsically biased, β-arrestin-coupled receptor, making them first-in-class dual agonists for chemokine receptors with exclusive βarr-bias at CXCR7. Taken together, our study provides molecular insights into ligand promiscuity and signaling bias at the chemokine receptors, and also demonstrates a proof of principle that naturally encoded structural mimicry can be recapitulated using synthetic pharmacophores with potential implications for developing novel therapeutics.

Structures of the human cholecystokinin receptors bound to agonists and antagonists

Structural basis for ligand recognition and G protein-coupling promiscuity of the cholecystokinin A receptor

Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor

Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist

Linking non-peptide ligand binding mode to activity at the human cholecystokinin-2 receptor

Structural insights into human brain–gut peptide cholecystokinin receptors

Partial agonism, neutral antagonism, and inverse agonism at the human wild-type and constitutively active cholecystokinin-2 receptors

Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor

Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor

Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling

Molecular mechanism of agonism and inverse agonism in ghrelin receptor

Structural basis of bile acid receptor activation and Gs coupling

Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding

Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor

Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin

Molecular basis for benzodiazepine agonist action at the type 1 cholecystokinin receptor

Structural basis for the ligand recognition and G protein subtype selectivity of kisspeptin receptor

Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies

Structural Basis of Agonist Selectivity for Different Nachr Subtypes: Insights from Crystal Structures, Mutation Experiments and Molecular Simulations

Molecular basis of ligand promiscuity, structural mimicry, and atypical dimerization in the chemokine receptors

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.